Study of the Effects of a Study Medication in Females with IC/Bladder Pain Syndrome

What we are studying

The purpose of this study is to see how safe and how well the study medication is for the potential treatment of institial cystitis/bladder pain syndrome. LiRIS is a pretzel-shaped device inserted into the bladder that releases a controlled amount of Lidocaine into the bladder. It is not FDA approved which is why the study is being done.

Who we are studying

  • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosis of IC/BPS

What is involved

  • Study participation 30 weeks (if completing entire study)
  • Medical history
  • Medication history
  • Physical
  • Post-Void residual
  • Blood draws
  • Questionnaires


The total amount compensated depends on the study visits the subject completes and whether or not the subject receives a second dose.

Contact Information

Study Coordinator
Janet Shuping
Principal Investigator
Robert J. Evans, M.D.

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.